Robert L. Trestman

ORCID: 0000-0003-0168-8057
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mental Health Treatment and Access
  • Substance Abuse Treatment and Outcomes
  • Mental Health Research Topics
  • Opioid Use Disorder Treatment
  • Healthcare Decision-Making and Restraints
  • Mental Health and Psychiatry
  • Schizophrenia research and treatment
  • Mental Health and Patient Involvement
  • Psychopathy, Forensic Psychiatry, Sexual Offending
  • Stress Responses and Cortisol
  • Crime Patterns and Interventions
  • Patient Satisfaction in Healthcare
  • Optical Imaging and Spectroscopy Techniques
  • Sleep and related disorders
  • Telemedicine and Telehealth Implementation
  • Digital Mental Health Interventions
  • Child and Adolescent Health
  • Homelessness and Social Issues
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Tryptophan and brain disorders
  • Neural and Behavioral Psychology Studies
  • Criminal Justice and Corrections Analysis
  • Ethics and Legal Issues in Pediatric Healthcare
  • Maternal Mental Health During Pregnancy and Postpartum
  • Psychosomatic Disorders and Their Treatments

Harvard University
2025

Johns Hopkins University
2025

Medical University of South Carolina
2025

Virginia Tech
2018-2023

Carilion Clinic
2018-2023

The American Psychiatric Association (APA) issued a 2023 report on the future of psychiatry, focusing how organization should position itself in relation to coming developments over next 10 years. Here, we follow up with discussion psychiatrist's role needs evolve adapt changes ahead.

10.1176/appi.prcp.20240130 article EN cc-by-nc-nd Psychiatric Research and Clinical Practice 2025-03-27

Opioid use disorder impedes dependent parents' abilities to care for their children. In turn, children may languish in unpredictability and persistent chaos. Societal responses these are often guided by a belief that unless the drug parent receives treatment, there is little help child. While preponderance of dependence research adult-centric, significant body demonstrates importance not only addressing immediate well being caregivers but preventing continuing cycle dependence. The present...

10.3389/fpubh.2018.00289 article EN cc-by Frontiers in Public Health 2018-10-16

Abstract Background Clinical trials provide consistent evidence for buprenorphine’s efficacy in treating opioid use disorder (OUD). While the Drug Addiction Treatment Act of 2000 requires physicians to combine medication-assisted treatment (MAT) with behavioral intervention, there is no clear what form or elements psychotherapy are most effective when coupled MAT treat OUD. This investigation involves focus groups designed collect patient opinions about a specific psychotherapy, called START...

10.1186/s12888-020-03024-x article EN cc-by BMC Psychiatry 2021-01-10

ESP | 中文 Responsibly determining whether and when to use potentially lifesaving force caring for patients who are acutely mentally ill typically requires carefully applying 2 key ethical standards. First

10.1001/amajethics.2021.292 article EN The AMA Journal of Ethic 2021-04-01

Introduction While the role of benzodiazepines (BZDs) has been well established for anxiety and related disorders, there are significant concerns about BZD dependence, withdrawal, tolerance. There is a lot ambiguity regarding potential long-term effects BZDs on mental health. However, risk developing subsequent other substance use disorders in question. Objectives In this electronic medical record (EMR) based retrospective cohort study, study was defined as patients between ages 18 65 with...

10.1192/j.eurpsy.2023.716 article EN cc-by-nc-nd European Psychiatry 2023-03-01

Medications for opioid use disorder (MOUD) such as buprenorphine is effective treating (OUD). START NOW (SN) a manualized, skills-based group psychotherapy originally developed and validated the correctional population has been shown to result in reduced risk of disciplinary infractions future psychiatric inpatient days with dose response effect. We investigate whether adapted OUD MOUD office-based treatment (OBOT) setting this non-inferiority clinical trial.

10.21203/rs.3.rs-3229052/v1 preprint EN cc-by Research Square (Research Square) 2023-08-11

Introduction: Medication-assisted treatment (MAT) with methadone or buprenorphine paired psychotherapy is effective for treating opioid use disorder (OUD). START NOW (SN) a manualized, skills-based group originally developed and validated the correctional population has been shown to result in reduced risk of disciplinary infractions future psychiatric inpatient days dose response effect. We investigate whether adapted OUD MAT office-based (OBOT) setting this non-inferiority clinical...

10.2139/ssrn.4201842 article EN SSRN Electronic Journal 2022-01-01
Coming Soon ...